Mark Shearman, CSO at Applied Genetic Technologies, holds 65.56K shares in Editas Medicine (Ticker: EDIT), holds 33.28K shares in Applied Genetic Technologies (Ticker: AGTC).

See the Hottest Stocks Based on Insider Trading >

Mark Shearman
Applied Genetic Technologies (AGTC)
CSO

Ranked #72,001 out of 98,743 Corporate Insiders

Profitable Transactions

1 out of 2 Profitable Transactions

Average Return

-28.30%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

EDIT

A breakdown of Mark Shearman's holdings

See the Top Stocks by Insiders

Insider Roles

Editas Medicine
(EDIT)

EVP, CHIEF SCIENTIFIC OFFICER

Roles that Mark Shearman holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Applied Genetic Technologies
(AGTC)

Rating:Informative Sell

Date:Dec 18, 2018 - Dec 18, 2019

Return:+2.40%

The most profitable trade made by Mark Shearman

See the Latest Stocks Traded by Insiders

Mark Shearman's Trading History

AGTC

Applied Genetic Technologies

Aug 18, 2020

―

Uninformative Sell

33.02K

$13.08K

EDIT

Editas Medicine

Feb 15, 2023

EVP, CHIEF SCIENTIFIC OFFICER

Uninformative Sell

26.95K

$371.06K

List of latest transactions for each holding click on a transaction to see Mark Shearman's performance on stock

See All Insider Trading from Today

Mark Shearman insider profile FAQ

What is the percentage of profitable transactions made by Mark Shearman?

The percentage of profitable transactions made by Mark Shearman is 50%.

What is the average return per transaction made by Mark Shearman?

The average return per transaction made by Mark Shearman is -28.30%.

What stocks does Mark Shearman hold?

Mark Shearman holds: AGTC, EDIT stocks.

What was Mark Shearman’s latest transaction?

Mark Shearman latest transaction was an Uninformative Sell of $26.95K.

What was Mark Shearman's most profitable transaction?

Mark Shearman’s most profitable transaction was an Informative Sell of AGTC stock on December 18, 2018. The return on the trade was 2.40%.

What is Mark Shearman's role in Applied Genetic Technologies?

Mark Shearman's role in Applied Genetic Technologies is CSO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Mark Shearman Insider Profile

Mark Shearman Applied Genetic Technologies (AGTC)CSO